+1 (855) PLE.XISION (753.9474) info@plexision.com

Who We are

You are here

Plexision develops cellular biomarkers for personalized diagnosis and drug development in solid organ transplantation, and immunological disorders.

Plexision's first patented product, the PleximmuneTM assay, predicts the risk of transplant rejection. The test is based on patent-pending technology to measure antigen-specific white blood cells.

Testing services for transplant recipients and drug developers are provided at Plexision’s CLIA-certified, central laboratory in Pittsburgh.

 


Warning: Cannot modify header information - headers already sent by (output started at /home/plexision/public_html/includes/common.inc:2777) in /home/plexision/public_html/includes/bootstrap.inc on line 1486

Warning: Cannot modify header information - headers already sent by (output started at /home/plexision/public_html/includes/common.inc:2777) in /home/plexision/public_html/includes/bootstrap.inc on line 1490

Warning: Cannot modify header information - headers already sent by (output started at /home/plexision/public_html/includes/common.inc:2777) in /home/plexision/public_html/includes/bootstrap.inc on line 1490

Warning: Cannot modify header information - headers already sent by (output started at /home/plexision/public_html/includes/common.inc:2777) in /home/plexision/public_html/includes/bootstrap.inc on line 1490
Who We are | Plexision

Error

The website encountered an unexpected error. Please try again later.